# BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/beyond-a-randomized-double-blind-placebo-controlled-multicenter-phase-iii-study/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Caicun Zhou,Yi‐Long Wu,Gongyan Chen,Xiaoqing Liu,Yunzhong Zhu,Shun Lü,Jifeng Feng,Jianxing He,Baohui Han,Jie Wang,Guoliang Jiang,Chunhong Hu,Hao Zhang,Gang Cheng,Xiangqun Song,You Lü,Hongming Pan,Wenjuan Zheng,Anny-Yue Yin |
| Citations | 391 |
| DOI | 10.1200/jco.2014.59.4424 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.59.4424?role=tab |
| OpenAlex ID | https://openalex.org/W2135140316 |
| PMID | 26014294 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Baohui Han](https://scholariq.org/researchers/baohui-han/)
- [You Lü](https://scholariq.org/researchers/you-lu/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.